Genetically engineered catfish for faster growth, higher body mass, and healthier omega-3 content

Background

The global demand for seafood continues to rise, placing immense pressure on the aquaculture industry to sustainably scale production. As wild fish populations face depletion, aquaculture has emerged as a critical field to ensure food security. Within the United States, catfish farming represents a vital economic sector and a primary source of domestically produced aquatic protein. To keep pace with the escalating dietary needs of a growing population, there is an urgent necessity for advanced agricultural solutions that can optimize yield, enhance nutritional profiles, and streamline commercial fish farming operations.

Despite its economic importance, the domestic catfish industry faces severe challenges. Current farming approaches are plagued by high production costs and intense competition from cheaper international imports. Traditional breeding methods are notoriously slow, often failing to produce fish with optimal growth rates or sufficient body mass to maximize profitability. Furthermore, standard farm-raised catfish naturally lack high levels of valuable nutrients, such as omega-3 fatty acids, which consumers demand. Farmers also struggle with devastating bacterial diseases that cause massive stock losses. Finally, traditional aquaculture poses significant biosafety risks, as fertile farmed fish can escape and disrupt local ecosystems, highlighting a critical flaw in current containment strategies.

Technology

This advanced aquaculture technology involves genetically engineering catfish using programmable nuclease systems, such as CRISPR-Cas9, to introduce precise modifications into one-cell stage embryos. Key features include the targeted knockout of endogenous myostatin (MSTN) and melanocortin-4 receptor (MC4R) genes. Furthermore, the solution enables the knock-in of exogenous genes directly into these loci, such as a masu salmon elongase gene for omega-3 fatty acid biosynthesis, or genes encoding antimicrobial peptides and growth hormones. The engineered fish also feature a built-in biosafety mechanism of sterility, which remains fully reversible for breeding purposes through targeted hormone therapies.

This technology is highly differentiated because it simultaneously solves multiple critical challenges in commercial aquaculture through a single genetic platform. Unlike traditional selective breeding, this solution immediately yields up to a 218% increase in body weight and accelerated growth rates, drastically reducing production costs. It uniquely elevates the nutritional profile of the fish by actively synthesizing high-value EPA and DHA omega-3 fatty acids, a trait not naturally prominent in catfish. Furthermore, the integration of antimicrobial peptides bolsters disease resistance, while the reversible sterility ensures strict environmental biosafety without sacrificing the ability to maintain commercial breeding lines.

Benefits

• Significantly increased growth rates and body mass, leading to higher yields and reduced production costs for aquaculture operations.
• Enhanced nutritional value in the final food product due to increased biosynthesis of beneficial omega-3 fatty acids (EPA and DHA).
• Improved disease resistance through the integration of antimicrobial peptides, promoting healthier fish populations and reducing potential losses.
• Enhanced environmental biosafety through engineered sterility, which prevents unwanted breeding with wild populations while allowing controlled reproduction via hormone therapy.
• Broad applicability across various commercial catfish species and hybrids, making it a highly versatile solution for the global seafood industry.

Applications

• Commercial high yield aquaculture
• Omega-3 rich seafood production
• Disease resistant catfish farming
• High nutrition animal feed
• Reversible sterile fish breeding

Additional info

These genetically modified catfish feature targeted knockouts of endogenous myostatin (MSTN) and melanocortin-4 receptor (MC4R) genes via programmable nucleases like CRISPR-Cas to accelerate growth and increase body mass. They incorporate knocked-in exogenous genes, such as salmon elongase, to enhance omega-3 fatty acid biosynthesis, or genes encoding antimicrobial peptides. Additionally, they exhibit reversible sterility that is manageable through hormone therapy to induce spawning.